Iron Status and Cardiopulmonary Physiology

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 19, 2016

Primary Completion Date

May 1, 2016

Study Completion Date

December 7, 2017

Conditions
Iron-deficiencyVentricular FunctionPulmonary Vascular Resistance AbnormalityAltitude Hypoxia
Interventions
DRUG

Ferric Carboxymaltose Injectable Product

iv iron infusion: 15 mg / kg up to a maximum 1g dose of Ferinject diluted in normal saline (0.9%) up to a total volume of 250 ml

DRUG

Normal Saline 0.9% Infusion Solution Bag

250 ml of normal (0.9%) saline given by intravenous infusion over 20 minutes. This constitutes the control for the iron infusion.

All Listed Sponsors
collaborator

University of Oxford

OTHER

lead

Royal Centre for Defence Medicine

OTHER_GOV

NCT03707249 - Iron Status and Cardiopulmonary Physiology | Biotech Hunter | Biotech Hunter